SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes:

• Reviewing and approving the interim results for the six months ended 30 June 2026 and authorising their publication.

• Considering the declaration, recommendation, or payment of a dividend, if any.

The announcement was signed by Chairman Wei Chunxian on 19 August 2026. As of that date, the board comprised five executive directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Chen Henan, and Liu Bingyang—and three independent non-executive directors—Tung Woon Cheung Eric, To Tsz Wan Vivien, and Huang Yining.